Abante Global Funds Abante Life Sciences Fund B EUR AccRegístrese para Ver el Rating |
Cómo se ha comportado este fondo | 31/10/2024 |
Crecimiento de 1.000 (EUR) | Gráfico Avanzado |
Fondo | 6,5 | -36,0 | -12,3 | 3,4 | 11,1 | |
+/-Cat | -12,8 | -33,0 | 0,5 | 2,4 | 7,0 | |
+/-Ind | -19,4 | -43,0 | -9,3 | -6,5 | 2,5 | |
Categoría: RV Sector Biotecnología | ||||||
Benchmark de la Categoría: Morningstar Gbl Biotechnolo... |
Estadística Rápida | ||
VL 19/11/2024 | EUR 8,27 | |
Cambio del día | 0,40% | |
Categoría Morningstar™ | RV Sector Biotecnología | |
ISIN | LU1894891966 | |
Patrimonio (Mil) 19/11/2024 | USD 11,11 | |
Patrimonio Clase (Mil) 19/11/2024 | EUR 0,22 | |
Comisión Máx. Suscripción | - | |
Gastos Corrientes 19/02/2024 | 3,47% |
Objetivo de inversión: Abante Global Funds Abante Life Sciences Fund B EUR Acc |
The investment objective of this fund is to achieve-long term capital growth either directly or via third party UCITS and/or UCIs which are themselves invested in the healthcare sector and wellness theme. There is however no guarantee that this objective will be achieved. The fund will invest (i) at least 75% of the total assets in Underlying Funds with an equity investment policy in the pharmaceutical, biotech, life sciences tools & services and healthcare equipment with no specific geographical restrictions nor stock market capitalisations, the remainder (ii) will be invested in government bonds, deposits and/or money markets instruments. Direct investment in bonds will only be made in investment grade OECD sovereign bonds. |
Returns | |||||||||||||
|
Gestión | ||
Nombre del gestor Fecha Inicio | ||
Not Disclosed 10/11/2021 | ||
Creación del fondo 14/05/2019 |
Anuncio publicitario |
Benchmark de la Categoría | |
Benchmark de fondos | Benchmark Morningstar |
Not Benchmarked | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Qué posee el fondo Abante Global Funds Abante Life Sciences Fund B EUR Acc | - |
|
|
5 mayores posic. | Sector | % |
No hay datos disponibles | ||
Incremento Reducción Nuevo desde la anterior cartera | ||
Abante Global Funds Abante Life Sciences Fund B EUR Acc |